vimarsana.com
Home
Live Updates
MorphoSys AG: MorphoSys Stops Work and Operations on Pre-Cli
MorphoSys AG: MorphoSys Stops Work and Operations on Pre-Cli
MorphoSys AG: MorphoSys Stops Work and Operations on Pre-Clinical Research Programs
MUNICH, GERMANY / ACCESSWIRE / March 2, 2023 / MorphoSys AG (FSE:MOR)(NASDAQ:MOR) today announced that the company will stop work and operations on its pre-clinical research programs to optimize its cost
Related Keywords
Germany ,
Boston ,
Massachusetts ,
United States ,
Munich ,
Bayern ,
Planegg ,
Dennis Riedl ,
Thomas Biegi ,
Julia Neugebauer ,
Eamonn Nolan ,
Jean Paul Kress ,
Morphosys Agview ,
Exchange Commission ,
Linkedin ,
Twitter ,
Chief Executive Officer ,
Morphosy Annual Report ,
Investor Relations ,
Morphosys ,
Stops ,
Work ,
Operations ,
Linical ,
Research ,
Programs ,